Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tripos, a Certara company, has released Discovery 360 (D360) Version 5.5, by expanding data access and analysis capabilities of previous D360 versions.
Subscribe to our email newsletter
Tripos provides scientific solutions enabling life science researchers to improve the efficiency of molecular discovery.
Certara focuses on reducing the barriers between the phases of research to speed discoveries in chemistry, and enabling pharmaceutical and biotechnology companies to achieve improvements in the development and use of therapeutic products.
Certara unites Tripos and Pharsight.
Pharsight provides software and scientific services to improve productivity and decision-making in clinical drug development.
Tripos CEO Jim Hopkins said scientists using D360 are better informed and can more broadly and deeply understand the information about their research project from the scientific detail to the logistical necessities, D360 represents a revolutionary improvement in how information is employed in research.
Tripos D360 product manager David Lowis said all data manipulations, analysis, and dataset visualization can now be automated, allowing users ‘one click access’ to the view of their data they need for their workflow.
"With this latest version, they can also incorporate data and information in their analyses that may not be available in corporate data systems, further improving communication and decision-making," Lowis said.